1 day Ago By ABMN Staff
Renaissance Technologies LLC raised its position in Kronos Bio, Inc. ( NASDAQ:KRON – Free Report ) by 19.7% during the fourth quarter, according to its most recent filing with the SEC.
The firm owned 1,171,808 shares of the company’s stock after purchasing an additional 192,754 shares during the period. Renaissance Technologies LLC’s holdings in Kronos Bio were worth $1,113,000 as of its most recent filing with the SEC. Separately, Peapod Lane Capital LLC acquired a new position in Kronos Bio in the fourth quarter valued at $534,000.
64.09% of the stock is currently owned by institutional investors. Kronos Bio Trading Up 1.
6 % Shares of KRON opened at $0.90 on Wednesday. The firm’s fifty day simple moving average is $0.
88 and its two-hundred day simple moving average is $0.93. Kronos Bio, Inc.
has a 12 month low of $0.69 and a 12 month high of $1.60.
The stock has a market capitalization of $54.81 million, a P/E ratio of -0.63 and a beta of 1.
78. Kronos Bio Profile ( Free Report ) Kronos Bio, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and other serious diseases in the United States. Its lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 2 clinical trial; and KB-9558, a core oncogenic transcription factor that drives multiple myeloma.
Featured Articles Want to see what other hedge funds are holding KRON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kronos Bio, Inc. ( NASDAQ:KRON – Free Report ).
Receive News & Ratings for Kronos Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kronos Bio and related companies with MarketBeat.com's FREE daily email newsletter ..
